期刊文献+

儿童特发性血小板减少性紫癜患者NK细胞及T淋巴细胞亚群变化及意义 被引量:3

Study on changes and clinical significance of lymphocyte subtypes and NK cells in children with idiopathic thrombocytopenic purpura
原文传递
导出
摘要 目的检测特发性血小板减少性紫癜(ITP)患者T淋巴细胞亚群及NK细胞的变化,探讨其在ITP发病机制中的作用。方法应用流式细胞术分别检测80例ITP及35例正常对照组T淋巴细胞亚群、NK细胞变化。结果 ITP患者CD3+、CD4+细胞百分比及CD4+/CD8+比值明显低于正常对照组(P<0.01),CD8+细胞百分比高于正常对照组(P<0.01)。NK细胞百分比明显低于正常对照组P<0.01)。结论及T淋巴细胞亚群及NK细胞的变化可较好的反映ITP的病理过程,对提高ITP的诊断水平及指导临床具有一定的使用价值。 Objective To test changes in T lymphocyte subsets and NK cells in patients with ITP and to discuss the related factors envolved in pathlg nalysis detect T lymphocyte and NK cells subtype enesis of ITP. Methods Using flow cytometric a- in 80 patients with ITP and 35 heaithy controls. Resoits The percentage of CD3^+ T lymphocyte and CD4^+ T lymphocyte and the ratio of CD4^+/CD4^+ in patients with ITP were obviously lower than those in healthy controls (P 〈0. 01 ) ,but the percentage of CD8^+ T lymphocyte was much higher (P 〈 0. 01 ), the percentage of NK cells was significantly lower than that in heaithy controls (P 〈 0. 01 ). Conclusions The changes in T lymphocyte and NK ceils subsets can reflect the pathogenesis of ITP well. What is more, the test of them has a certain practical value in improving the diagnosis of ITP and guiding clinic.
出处 《医药论坛杂志》 2011年第19期24-25,共2页 Journal of Medical Forum
关键词 血小板减少性紫癜 T淋巴细胞亚群 NK细胞 Thrombocytopenic purpura T lymphocyte subsets NK cells
  • 相关文献

参考文献5

  • 1McFarland J. Pathoph - ysiology of platet destruction inimmune (idiopathic) thrombocytopenic purpura [ J ]. Blood Rew, 2002, 16 (l) :1-2.
  • 2张之南.血液病诊断及疗效标准[M].3版.北京:科学出版社,2008:1.
  • 3Semple JM. T cell and cytokine abnormalities in patients with autoimmune thrombocytopenic purpura [ J ]. Trans- fus Apheresis Sci,2003,28:237-242.
  • 4李美玲,杨林花,朱镭,张莉.T淋巴细胞亚群在特发性血小板减少性紫癜患者中的表达及意义[J].中国药物与临床,2011,11(4):408-409. 被引量:9
  • 5Johansson U, Macey MG, Kenny D, et el. The role of natural killer T (NKT)cell in immune thrombocytope- nia:is strong in vitro NKT cell acivity related to the de- velopment of the development of remission [ J ]. Br J Haematol,2005 ,129 :564-564.

二级参考文献7

  • 1张之南.血液病诊断及疗效标准.3版.北京:科学出版社,2008.106-113.
  • 2Semple JW. T cell and cytokine abnormalities in patients with autoimmune thromboeytopenie purpura. Transfus Apheresis Sci, 2003,28 : 237-242.
  • 3Kuwana M, Kaburakki J,Ikeda Y. Autoreactive T cell to platelet GP Ⅱb/Ⅲa in immune thrombocytopenic purpura:role in production of antiplatelet autoantibody. J Clin Invest, 1998,102 : 1393- 1402.
  • 4Semple JW, lazarus AH, Freedman J, et al. The cellular immunology associated with autoimmune thrombocytopenic purpura:an update. Transfus Sci, 1998,19: 245-251.
  • 5Mylvaganam R,Ahn YS,Sprinz PG,et al. Sex difference in the CD4+ CD45+ R+ lymphocytes in normal individuals and its selective disease in woman with idiopathic thrombocytopenic purpura. Clin Immunol, 1989,52:473-485.
  • 6Shannon KM, Buchanan GR, Fink CW, et al. Lymphocyte populations in childhood immune thrombocytopenic purpura. Am J Dis Child, 1984, 138 : 64-65.
  • 7Johansson U,Macey MG,Kenny D,et al. The role of natural killer T (NKT) cells in immune thrombocytopenia:is strong in vitro NKT cell activity related to the development of remission. Br J Haematol, 2005,129: 564-565.

共引文献90

同被引文献33

  • 1涂亚兰.CD_4^+CD_(25)^+调节性T细胞在儿童特发性血小板减少性紫癜患者中的表达及意义[J].现代中西医结合杂志,2007,16(11):1454-1455. 被引量:4
  • 2Czemiecki BJ,Koski GK, Koldovsky U, et al. TargetingHER-2/neu in early breast cancer development using den-dritic cells with staged interleukin-12 burst secretion [ J ].Cancer Res,2007,67(4) :1 842 -1 852.
  • 3Cines DB,Liebman HA. The immune thrombocytopenia syn-drome^ disorder of diverse pathogenesis and clinical pres-entation[ J]. Hematol Oncol Clin North Am,2009,23(6):1 155 -1 161.
  • 4Mittal S, Blaylock MG, Culligan DJ, et al. A high rate ofCLL phenotype lymphocytes in autoimmune hemolytic ane-mia and immune thrombocytopenic purpura[ J] . Haemato-logica,2008,93(1) :151 -152.
  • 5Chong BH. Primary immune thrombocytopenia ( ITP ) : Understanding pathogenesis is the key to bettter treatments [ J ]. Thromb Haematol, 2009,7(2) :319-321.
  • 6Mah6vas M, Patin P, Huetz F, et al. B cell depletion in immune throm- bocytopenia reveals splenic long-lived plasma cells[ J]. J Clin Invest, 2013,123 ( 1 ) :432-442.
  • 7Li X, Zhong H, Bao W, et al. Defective regulatory B-cell compartment in patients with immune thrombocytopenia [ J]. Blood, 2012, 120 (16) :3318-3325.
  • 8Patel VL, Mah6vas M, Lee SY, et al. Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocyto- penia [ J]. Blood ,2012,119 (25) :5989-5995.
  • 9Godeau B. B-cell depletion in immune thrombocytopenia [ J ]. Semin Hemato1,2012,50( 1 ) :89-99.
  • 10Mantadakis E, Farmaki E, Buchanan GR. Thrombocytopenic purpura after measles-mumps-rubella vaccination: a systematic review of the literature and guidance for management [ J ]. Pediatr, 2010,156 : 623- 628.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部